• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿酸钠晶种引发草酸钙的异质成核作用。

Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate.

作者信息

Pak C Y, Arnold L H

出版信息

Proc Soc Exp Biol Med. 1975 Sep;149(4):930-2. doi: 10.3181/00379727-149-38929.

DOI:10.3181/00379727-149-38929
PMID:241081
Abstract

Seeds of monosodium urate caused heterogeneous nucleation of calcium oxalate at pH 5.7 and 6.7, and of calcium phosphate at pH 5.3, 5.7, and 6.7 from metastably supersaturated solutions in vitro. Seeds of uric acid had a small or no effect. The results could account for the formation of calcium stones among patients with hyperuricosuria and normocalciuria.

摘要

尿酸钠晶种在体外pH值为5.7和6.7时可引发草酸钙的异相成核,在pH值为5.3、5.7和6.7时可引发磷酸钙的异相成核,这些晶种来自亚稳态过饱和溶液。尿酸晶种的影响很小或没有影响。这些结果可以解释高尿酸尿症和正常钙尿症患者中钙结石的形成。

相似文献

1
Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate.尿酸钠晶种引发草酸钙的异质成核作用。
Proc Soc Exp Biol Med. 1975 Sep;149(4):930-2. doi: 10.3181/00379727-149-38929.
2
Effect of seed crystals of uric acid and monosodium urate on the crystallization of calcium oxalate in undiluted human urine in vitro.尿酸和尿酸钠晶种对体外未稀释人尿中草酸钙结晶的影响。
Clin Sci (Lond). 1997 Feb;92(2):205-13. doi: 10.1042/cs0920205.
3
Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate.尿酸盐、磷酸钙和草酸钙的异质成核作用。
Proc Soc Exp Biol Med. 1976 Oct;153(1):83-7. doi: 10.3181/00379727-153-39485.
4
Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation.尿酸钠对糖胺聚糖抑制草酸钙成核作用的衰减。
Invest Urol. 1979 Sep;17(2):138-40.
5
Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.枸橼酸钾成功治疗高尿酸尿草酸钙肾结石病
Arch Intern Med. 1986 May;146(5):863-7.
6
Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate.尿酸钠和尿酸晶体对草酸钙结晶的影响。
Urol Res. 1984;12(1):11-5. doi: 10.1007/BF00256303.
7
Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.特发性复发性草酸钙尿石症男性患者餐后尿中草酸钙成核与磷酸钙成核及结石形成强度有关吗?有助于深入了解尿游离柠檬酸盐和蛋白质可能作用的研究。
Clin Chem Lab Med. 2004 Mar;42(3):283-93. doi: 10.1515/CCLM.2004.052.
8
Uric acid saturation in calcium nephrolithiasis.钙肾结石中的尿酸饱和度
Kidney Int. 1980 May;17(5):662-8. doi: 10.1038/ki.1980.205.
9
Sodium urate accelerates precipitation of calcium oxalate in vitro.尿酸钠在体外可加速草酸钙的沉淀。
Proc Soc Exp Biol Med. 1975 Sep;149(4):926-9. doi: 10.3181/00379727-149-38928.
10
The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid.
Invest Urol. 1976 Sep;14(2):115-9.

引用本文的文献

1
Kidney stone disease: risk factors, pathophysiology and management.肾结石疾病:危险因素、病理生理学及管理
Nat Rev Nephrol. 2025 Aug 11. doi: 10.1038/s41581-025-00990-x.
2
Medical management of urolithiasis: Great efforts and limited progress.尿石症的医学管理:付出巨大努力但进展有限。
Asian J Urol. 2024 Apr;11(2):149-155. doi: 10.1016/j.ajur.2023.05.001. Epub 2023 Jun 29.
3
Uric Acid and Urate in Urolithiasis: The Innocent Bystander, Instigator, and Perpetrator.尿酸和尿石症中的尿酸盐:无辜的旁观者、始作俑者和元凶。
Semin Nephrol. 2020 Nov;40(6):564-573. doi: 10.1016/j.semnephrol.2020.12.003.
4
Hyperuricosuric calcium urolithiasis.高尿酸尿钙结石。
J Nephrol. 2018 Apr;31(2):189-196. doi: 10.1007/s40620-018-0469-3. Epub 2018 Jan 24.
5
Postmenopausal hormone and the risk of nephrolithiasis: A meta-analysis.绝经后激素与肾结石风险:一项荟萃分析。
EXCLI J. 2017 Jun 30;16:986-994. doi: 10.17179/excli2017-304. eCollection 2017.
6
Precipitation and Solubility of Calcium Hydrogenurate Hexahydrate.六水合尿酸氢钙的沉淀与溶解性
J Res Natl Inst Stand Technol. 1992 May-Jun;97(3):365-372. doi: 10.6028/jres.097.015.
7
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.钙肾结石及其全身表现的代谢诊断与医学预防:共识声明
J Nephrol. 2016 Dec;29(6):715-734. doi: 10.1007/s40620-016-0329-y. Epub 2016 Jul 25.
8
Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.纳米尿酸或纳米磷酸钙作为诱导草酸钙结石形成的核心病灶:一项关于尿纳米微晶的高分辨率透射电子显微镜研究
Int J Nanomedicine. 2014 Sep 16;9:4399-409. doi: 10.2147/IJN.S66000. eCollection 2014.
9
Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.临床综述。2012 年肾结石:发病机制、诊断与治疗。
J Clin Endocrinol Metab. 2012 Jun;97(6):1847-60. doi: 10.1210/jc.2011-3492. Epub 2012 Mar 30.
10
Differences in Urinary Stone Composition according to Body Habitus.根据体型分类的尿石成分差异
Korean J Urol. 2011 Sep;52(9):622-5. doi: 10.4111/kju.2011.52.9.622. Epub 2011 Sep 28.